In this issue:
Leukaemia selection
Cytotoxic lymphocyte expansion contributes to dasatinib response in chronic-phase CML
Diagnosing and managing of AML during pregnancy
Lymphoma selection
Prognostic significance of cell of origin in DLBCL
Splenectomy for improving survival in primary splenic DLBCL
Early FL relapse after R-CHOP defines mortality risk
Long-term MCL outcomes after single-agent ibrutinib
Salvage chemotherapy and autologous SCT for TRIL
GZL with features between classical HL and DLBCL
Long-term course of stage IA nodular lymphocyte-predominant HL
Please login below to download this issue (PDF)